Cvac stock alert: halper sadeh llc is investigating whether the sale of curevac n.v. is fair to shareholders

New york--(business wire)--halper sadeh llc, an investor rights law firm, is investigating whether the sale of curevac n.v. (nasdaq: cvac) to biontech se is fair to curevac shareholders. under the terms of the proposed transaction, each curevac share will be exchanged for approximately $5.46 in biontech adss. upon closing of the proposed transaction, curevac shareholders are expected to own between 4% and 6% of biontech. halper sadeh encourages curevac shareholders to click here to learn more a.
CVAC Ratings Summary
CVAC Quant Ranking